Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TPEX/6621 stock hub

TPEX/6621 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/6621is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

431.3M

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/6621

In the news

Latest news · TPEX/6621

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/En/a

P25 14.4P50 18P75 31.9

ROE-15.8

P25 -16.2P50 0.3P75 9.8

ROIC-41.9

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/6621 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

170

Groups with data

Currency

TWD

Showing 170 of 170 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees	31
Employees Change	-11%
Employees Change Percent	-26.19
Enterprise value	TWD 306.9M
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	TW0006621006
Last refreshed	2026-05-10
Market cap	TWD 431.3M
Price	TWD 12.15
Price currency	TWD
Sector	Healthcare
Sic	5047
Symbol	tpex/6621
Website	https://www.uni-pharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-9.4%
EV Earnings	-7.57x
EV/FCF	-8.08x
EV/Sales	3.47x
FCF yield	-8.8%
P/B ratio	1.88x
P/S ratio	4.88x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-49.89%
EBITDA Margin	-46.24%
Gross margin	53.39%
Gross Profit	TWD 47.2M
Gross Profit Growth	-0.7%
Gross Profit Growth Q	-1.37%
Gross Profit Growth3 Y	0.24%
Gross Profit Growth5 Y	-7.61%
Net Income	TWD -40.5M
Net Income Growth Years	0%
Pretax Margin	-45.84%
Profit Margin	-45.84%
ROA	-9.13
Roa5y	-6.04
ROCE	-18.61
ROE	-15.76
Roe5y	-11.1
ROIC	-41.86
Roic5y	-22.99

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-16.03%
Cagr3y	-10.89%
Cagr5y	-0.64%
EPS Growth Years	0
Revenue Growth	-5.36x
Revenue Growth Q	-5.04x
Revenue Growth Years	0x
Revenue Growth3 Y	-3.87x
Revenue Growth5 Y	-6.58x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.29
Assets	TWD 275M
Cash	TWD 135.4M
Current Assets	TWD 184.5M
Current Liabilities	TWD 37.9M
Debt	TWD 11M
Debt Equity	TWD 0.05
Debt FCF	TWD -0.29
Equity	TWD 229.8M
Interest Coverage	-445.7
Liabilities	TWD 45.2M
Long Term Assets	TWD 90.5M
Long Term Liabilities	TWD 7.3M
Net Cash	TWD 124.4M
Net Cash By Market Cap	TWD 28.84
Net Cash Growth	-12.64%
Net Debt Equity	TWD -0.54
Tangible Book Value	TWD 226.3M
Tangible Book Value Per Share	TWD 6.37
WACC	3.18

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.86
Inventory Turnover	1.54
Net Working Capital	TWD 14.9M
Quick ratio	3.96
Working Capital	TWD 146.5M
Working Capital Turnover	TWD 0.56

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-16.02%
200-day SMA	12.68
3Y total return	-29.25%
50-day SMA	12.98
50-day SMA vs 200-day SMA	50over200
5Y total return	-3.17%
All Time High	93
All Time High Change	-86.94%
All Time High Date	2020-07-08
All Time Low	6.19
All Time Low Change	96.28%
All Time Low Date	2020-03-19
ATR	0.79
Beta	-0.18
Beta1y	0.12
Beta2y	0.24
High	12.55
High52	16
High52 Date	2026-04-23
High52ch	-24.06%
Low	12.15
Low52	11.4
Low52 Date	2025-09-10
Low52ch	6.58%
Ma50ch	-6.39%
Price vs 200-day SMA	-4.21%
RSI	42.37
RSI Monthly	43.11
RSI Weekly	44.64
Sharpe ratio	-0.45x
Sortino ratio	-0.56
Tr YTD	1.61
Tr1m	-8.3%
Tr1w	-1.22%
Tr3m	-2.02%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD -44.1M
Operating margin	-49.89

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	27,158,810%
Net Borrowing	-3,675,000
Shares Insiders	2.27%
Shares Out	35,501,000
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD -38M
Average Volume	261,136.5x
Bv Per Share	6.47
CAPEX	TWD -1.3M
Ch1m	-8.3
Ch1w	-1.22
Ch1y	-17.35
Ch3m	-2.02
Ch3y	-30.37
Ch5y	-4.71
Ch6m	-1.62
Change	-0.82%
Change From Open	-1.62
Close	12.25
Days Gap	0.82
Depreciation Amortization	3,232,000
Dollar Volume	1,960,256.7
Earnings Date	2026-05-20
EBIT	TWD -44.1M
EBITDA	TWD -40.9M
EPS	TWD -1.14
F Score	3
FCF	TWD -38M
FCF EV Yield	-12.37x
FCF Per Share	TWD -1.07
Financing CF	-3,675,000
Fiscal Year End	December
Founded	1,998
Investing CF	10,671,000
Is Primary Listing	1
Last Earnings Date	2025-11-13
Last Report Date	2025-12-31
Ma150	12.6
Ma150ch	-3.6%
Ma20	12.87
Ma20ch	-5.58%
Net CF	-29,678,000
Next Earnings Date	2026-05-20
Open	12.35
Position In Range	0
Ppne	18,557,000
Price Date	2026-05-08
Ptbv Ratio	1.91
Relative Volume	0.62x
Revenue	88,444,000x
Tr6m	-0.04%
Volume	161,338
Z Score	6.24

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TPEX/6621 pay a dividend?

Capital-return profile for this ticker.

Performance

TPEX/6621 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/6621?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+2.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

TPEX/6621 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.4

Neutral momentum band

Price vs 200-day MA

-4.2%

50/200-day relationship not available

Beta (5Y)

-0.18

Less volatile than the market

Sharpe ratio

-0.45

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/6621

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/6621 stock rating?

tpex/6621 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/6621 analysis?

The full report lives at /stocks/tpex/6621/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/6621?

The latest report frames tpex/6621 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/6621 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.